NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

ICICI Securities Downgrades Ambuja Cements to HOLD Amidst Disappointing Q4FY26

Ambuja Cements (ACEM) has reported a disappointing quarter for Q4FY26, with earnings before interest, tax, depreciation, and amortization (EBITDA) slipping 22% year-over-year (YoY) due to lower-than-expected organic volume growth. Despite reported volumes rising approximately 10%, the company's high operating cost has further exacerbated the situation. In response to these challenges, ACEM is shifting its focus towards stabilizing its newly commissioned capacities and increasing the utilization of its existing assets.

As a result, the company's FY28 capacity target of 155 million tons per annum (mtpa) is being recalibrated. The demand headwinds, largely driven by the expectation of a below-normal monsoon in the current year, and the elevated competitive intensity amidst rising global fuel costs have also contributed to the downward revision. In light of these factors, ICICI Securities has chopped its earnings estimates for FY27E and FY28E by 26% and 21%, respectively.

Earnings Estimate RevisionFY27EFY28E
Original Estimate--
Revised Estimate-26%-21%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In light of these developments, ICICI Securities has downgraded Ambuja Cements to HOLD from its earlier recommendation of ADD, with a revised target price of INR 431. This valuation is based on an unchanged enterprise value to earnings before interest, tax, depreciation, and amortization (EV/EBITDA) multiple of 15x for FY28E.

Investor Takeaway

ICICI Securities downgrades Ambuja Cements to HOLD with a revised price target of Rs 431.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.